Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study

Saved in:
Bibliographic Details
Published in:Rheumatology and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301676185026560
collection WordPress RSS
FRELIP Feed Integration
container_title Rheumatology and Therapy
description
discipline_display Rheumatology
discipline_facet Rheumatology
format Online Article
RSS Article
genre Journal Article
id rss_article:58294
institution FRELIP
journal_source_facet Rheumatology and Therapy
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study
Rheumatology
General
Rheumatology
sub_discipline_display General
sub_discipline_facet General
subject_display Rheumatology
General
Rheumatology
Rheumatology
General
Rheumatology
subject_facet Rheumatology
General
Rheumatology
title Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study
title_auth Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study
title_full Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study
title_fullStr Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study
title_full_unstemmed Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study
title_short Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study
title_sort pharmacokinetics of certolizumab pegol in pregnancy: results from the open-label cherish study
topic Rheumatology
General
Rheumatology
url https://link.springer.com/article/10.1007/s40744-026-00853-2